Commonwealth Equity Services, LLC Exact Sciences Corp Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 96,723 shares of EXAS stock, worth $5.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
96,723
Previous 105,083 7.96%
Holding current value
$5.56 Million
Previous $4.44 Million 48.4%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
$42.43 - $70.83 $354,714 - $592,138
-8,360 Reduced 7.96%
96,723 $6.59 Million
Q2 2024

Jul 31, 2024
BUY
$41.33 - $74.26 $530,842 - $953,795
12,844 Added 13.92%
105,083 $4.44 Million
Q1 2024

Apr 29, 2024
BUY
$56.27 - $73.77 $890,472 - $1.17 Million
15,825 Added 20.71%
92,239 $6.37 Million
Q4 2023

Feb 06, 2024
BUY
$59.06 - $75.72 $166,549 - $213,530
2,820 Added 3.83%
76,414 $5.65 Million
Q3 2023

Oct 23, 2023
SELL
$65.94 - $99.04 $15,166 - $22,779
-230 Reduced 0.31%
73,594 $5.02 Million
Q2 2023

Aug 10, 2023
BUY
$62.68 - $95.05 $27,015 - $40,966
431 Added 0.59%
73,824 $6.93 Million
Q1 2023

May 11, 2023
SELL
$47.19 - $70.77 $119,956 - $179,897
-2,542 Reduced 3.35%
73,393 $4.98 Million
Q4 2022

Feb 07, 2023
SELL
$30.35 - $53.15 $19,818 - $34,706
-653 Reduced 0.85%
75,935 $3.76 Million
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $101,472 - $156,700
3,174 Added 4.32%
76,588 $2.49 Million
Q2 2022

Jul 19, 2022
BUY
$35.61 - $76.23 $57,616 - $123,340
1,618 Added 2.25%
73,414 $2.89 Million
Q1 2022

May 04, 2022
SELL
$57.56 - $82.54 $118,573 - $170,032
-2,060 Reduced 2.79%
71,796 $5.02 Million
Q4 2021

Jan 31, 2022
BUY
$72.5 - $100.68 $97,005 - $134,709
1,338 Added 1.85%
73,856 $5.75 Million
Q3 2021

Oct 29, 2021
BUY
$90.24 - $124.05 $730,673 - $1 Million
8,097 Added 12.57%
72,518 $6.92 Million
Q2 2021

Aug 11, 2021
BUY
$93.66 - $139.27 $1.08 Million - $1.61 Million
11,567 Added 21.88%
64,421 $8.01 Million
Q1 2021

May 04, 2021
BUY
$116.57 - $155.01 $1.25 Million - $1.66 Million
10,707 Added 25.4%
52,854 $6.97 Million
Q4 2020

Feb 11, 2021
SELL
$99.61 - $142.12 $376,127 - $536,645
-3,776 Reduced 8.22%
42,147 $5.58 Million
Q3 2020

Nov 05, 2020
SELL
$72.92 - $102.01 $223,864 - $313,170
-3,070 Reduced 6.27%
45,923 $4.68 Million
Q2 2020

Aug 12, 2020
BUY
$55.75 - $92.75 $5,296 - $8,811
95 Added 0.19%
48,993 $4.26 Million
Q1 2020

May 11, 2020
BUY
$37.9 - $104.44 $389,308 - $1.07 Million
10,272 Added 26.59%
48,898 $2.84 Million
Q4 2019

Feb 05, 2020
BUY
$77.66 - $99.74 $864,200 - $1.11 Million
11,128 Added 40.47%
38,626 $3.57 Million
Q3 2019

Oct 30, 2019
BUY
$90.37 - $122.49 $114,408 - $155,072
1,266 Added 4.83%
27,498 $2.48 Million
Q2 2019

Jul 19, 2019
SELL
$89.51 - $118.04 $123,165 - $162,423
-1,376 Reduced 4.98%
26,232 $3.1 Million
Q1 2019

May 13, 2019
BUY
$61.98 - $96.5 $21,631 - $33,678
349 Added 1.28%
27,608 $2.39 Million
Q4 2018

Feb 11, 2019
BUY
$56.04 - $82.66 $335,455 - $494,802
5,986 Added 28.14%
27,259 $1.72 Million
Q3 2018

Nov 06, 2018
BUY
$48.29 - $80.6 $105,899 - $176,755
2,193 Added 11.49%
21,273 $1.68 Million
Q2 2018

Jul 31, 2018
BUY
$37.84 - $69.96 $103,341 - $191,060
2,731 Added 16.7%
19,080 $1.14 Million
Q1 2018

May 14, 2018
SELL
$39.82 - $57.53 $995 - $1,438
-25 Reduced 0.15%
16,349 $659,000
Q4 2017

Feb 12, 2018
BUY
$46.49 - $60.51 $761,227 - $990,790
16,374
16,374 $860,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email